INS and type 1 diabetes mellitus: In a recent type 1 diabetes, prevention trial oral insulin was given to prediabetic patients based on evidence from animal models which showed that oral insulin could induce anti-inflammatory immune activation to suppress anti-islet responses, however, the delayed disease progression was observed only in a subgroup of patients (22).